Research Article Details

Article ID: A21252
PMID: 25454300
Source: Clin Liver Dis
Title: Contemporary assessment of hepatic fibrosis.
Abstract: Newer noninvasive tests have begun to replace liver biopsy for staging purposes. The clinician must evaluate these tools and apply them to individual patients. None of these modalities give the exact same staging of fibrosis as a liver biopsy, but they are excellent tools for risk stratification. Still, it should be recognized that there are disease-specific issues with different utilizations and cutoffs for different clinical diseases. This article provides a framework for incorporating the use of serum biomarkers and elastography-based approaches to stage fibrosis into clinical practice. This review also covers recent developments in this rapidly advancing area.
DOI: 10.1016/j.cld.2014.09.007